19, the National Association of Attorneys General submitted a letter to acting FDA commissioner Sara Brenner, MD, MPH, asking the agency to take decisive action against bad actors unlawfully profiting off the high demand for FDA-approved weight loss and diabetes drugs. While states play a role in protecting their own consumers, many organizations that sell unsafe, unregulated versions of GLP-1 operate outside the country, the letter stated
Metabolic Syndrome, Insulin Resistance and Menopause: The Changes in Body Structure and the Therapeutic Approach. Gynecological and Reproductive Endocrinology & Metabolism , vol
True enough, but that's not all that it takes to get things back on track
Larger peptides with post-translational modifications (like the fatty diacid moiety on retatrutide) are more susceptible to degradation than simpler sequences
75% of US consumers say GLP-1s are a useful tool, not a magic cure - but 61% of users admit it can feel like cheating. The stigma is fading fast